🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

HRS-AKI ongoing ... Take your practical tips for the day. 👌 Dr. Mahak sharing a nephrologist's perspective of HRS-AKI. Urmila Anandh Swarnalatha Guditi Krithika Mohan

❓How do biomarkers help in HRS-AKI? Urinary NGAL is higher in ATN-AKI and in non-responders to terlipressin . Swarnalatha Guditi Krithika Mohan Urmila Anandh

Management of HRS-AKI .. Urmila Anandh Swarnalatha Guditi Krithika Mohan

💡Terlipressin versus Norepinephrine : Some key points .. Swarnalatha Guditi Urmila Anandh Krithika Mohan

Extracorporeal Therapy in Liver failure. Here what Dr. Ritika bansal is sharing with us .. A beautful start.. 👌

👉We don't know about the exact time of the start of RRT. 👉APASAL 2024 recommends RRT in patients in stage 3 AKI within 12-24 hours (if progressive). 👉 Evidence from several trials Urmila Anandh Swarnalatha Guditi Krithika Mohan

👉"ECADS helps in removing toxins and inflammatory markers" 👉"MARS is a costly therapy" .. Still an area of exploration. Some concluding slides from Dr. Ritika

Moving further ...

💡Why SKLT ? 💡How does MELD score helps in SLKT ? Urmila Anandh Swarnalatha Guditi Krithika Mohan Sneha Joy

⏩SKLT improves HRS in most patients , But is it rue for all ?? ⏩ Factors for non-reversal are : 🎯 Length of HRS-1 🎯 Duration of Dialysis(>6 weeks) 🎯 Pre-transplant S Cr

❓How do you prioritize your patients with SLKT? 💡Safety Net criteria can help.

❓Evaluation of SKLT? Is it different from the usual kidney donor workup?? 💡Induction with ATG—start Tac later. 💡These patients have good immune tolerance. Urmila Anandh Swarnalatha Guditi Krithika Mohan

💡Outcome of SKLT 💡Take home message Urmila Anandh Swarnalatha Guditi Krithika Mohan Sneha Joy

Hello, everyone !! This is Medhavi from WIN-India #SoMe team covering today's session from the North Zone. Signing off from WIN-India for now. Thank you to all the speakers, panelists, chairpersons, and attendees for joining us today !! Follow us for more updates.

💥Soul study group recently shared the result of their study :✔️ Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes NEJM 🟡 n=9650 🟡 42.4 %had history of CKD 🟡 Majority CVD ❄️FOR CV disorders results were superior, not so for kidneys 🧐 Here is my VA 👇

The follow-up to the Political Declaration of the Third #UNHLM on #NCDs is underway at #WHA78. A key item on the agenda is the vote on the resolution "Reducing the burden of non-communicable diseases through promotion of kidney health and strengthening prevention and control of

_Early bird deadline is approaching fast_ Get ready to level up your skills in upcoming 2nd annual conference of Avatar India Society - *AVATAR India 2025* Register Now Tap to register: avatarindia2025.com/registration.p…